Skip to main
We’re doing some system maintenance

Posts & Investments - #psilocybin

Invested in Mind Medicine MindMed
I truly believe that #psilocybin is the future, so adding some more to my portfolio while it’s at a low. #possibilities
3
0
Invested in COMPASS Pathways
I bought my first shares of this company last year on my old Stash account. After not seeing much movement it soared wonderfully and doubled the Orig investment when it hit $48 a share. Even though it’s sunk since, I’m hoping that the need for new treatments in the field of mental health will drive the demand for these treatments up. As someone who has, & does struggle with mental health issues I’m also trying to “put my money where my mouth is” by investing in innovative treatments that I know all to well are desperately needed. Most antidepressants are at best ineffective, or at worst, ineffective with horrible side effects. Sadly, this is actually a KNOWN and openly discussed topic amongst Mental Health Specialists that often isn’t shared with patients. Leading many to try medication after ineffective medication. Treatments like Psilocybin and Ketamine have shown extremely promising results so far but, as new treatments usually are, they are out of reach financially for most, & those who often need it most. Investments like these, are some of the only ones I can actually say I invest my heart into as well. #longterm #growth #possibilities #mentalhealth #mentalhealthmatters #innovation #psilocybin #ketamine
Tipped
0
0
Added Cybin to Watchlist
I fully believe in the positive impact that #psychedelics and #psilocybin can have on mental health, and I’m curious to see how stocks within the psychedelic industry perform, especially as my home state, California, moves closer to legalizing it. Thoughts on #psychedelicstocks? Are you investing now? #possibilities #opportunities #longterm #learning #invest #mentalhealth
0
0
Own your future.
Build your portfolio.
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Our clearing firm, Apex Clearing Corporation, has purchased an additional insurance policy. The coverage limits provide protection for securities and cash up to an aggregate of $150 million, subject to maximum limits of $37.5 million for any one customer’s securities and $900,000 for any one customer’s cash. Similar to SIPC protection, this additional insurance does not protect against a loss in the market value of securities.

Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are over-the-counter equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). Dalmore and Open to the Public Investing are not affiliated entities. This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures, Apex Crypto.

Dalmore and Apex Crypto, LLC are not affiliated with any of the Public Holdings subsidiaries.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically. Keep in mind that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more. All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.